CSS
STRO icon

Cubist Systematic Strategies’s Sutro Biopharma STRO Stock Holding History

Cubist Systematic Strategies’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$9 Sell
1
-607
-100% -$5.17K ﹤0.01% 2946
2025
Q2 		$4.34K Buy
+608
New +$4.97K ﹤0.01% 2858
2024
Q3 		– Sell
-1,646
Closed -$48.2K – 3478
2024
Q2 		$48.2K Sell
1,646
-17,721
-92% -$701K ﹤0.01% 2711
2024
Q1 		$1.09M Buy
19,367
+11,754
+154% +$519K 0.01% 2094
2023
Q4 		$327K Buy
+7,613
New +$242K ﹤0.01% 2757
2023
Q3 		– Sell
-1,652
Closed -$76.8K – 3880
2023
Q2 		$76.8K Sell
1,652
-11,631
-88% -$579K ﹤0.01% 3043
2023
Q1 		$614K Buy
13,283
+4,744
+56% +$301K ﹤0.01% 2530
2022
Q4 		$690K Sell
8,539
-25,799
-75% -$1.79M ﹤0.01% 2775
2022
Q3 		$1.91M Buy
34,338
+9,299
+37% +$550K 0.01% 2058
2022
Q2 		$1.3M Buy
25,039
+16,482
+193% +$921K 0.01% 2246
2022
Q1 		$703K Buy
+8,557
New +$814K 0.01% 2301
2021
Q4 		– Sell
-551
Closed -$104K – 3621
2021
Q3 		$104K Sell
551
-2,299
-81% -$437K ﹤0.01% 2736
2021
Q2 		$530K Sell
2,850
-1,066
-27% -$209K 0.01% 1969
2021
Q1 		$891K Buy
3,916
+2,266
+137% +$538K 0.01% 1611
2020
Q4 		$358K Buy
1,650
+627
+61% +$104K ﹤0.01% 1948
2020
Q3 		$103K Buy
1,023
+970
+1,830% +$91.6K ﹤0.01% 2282
2020
Q2 		$4K Buy
+53
New +$5.09K ﹤0.01% 2354
2019
Q3 		– Sell
-96
Closed -$11K – 2465
2019
Q2 		$11K Buy
+96
New +$10.6K ﹤0.01% 2403

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Cubist Systematic Strategies's STRO Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its Sutro Biopharma (STRO) stake by 100% in Q3 2025, selling an estimated $5.17K and leaving 1 share worth $9. The position accounts for ﹤0.01% of the portfolio, ranked #2946.

Cubist Systematic Strategies first reported a position in STRO in Q2 2019 and has held it in 18 quarters since. The position peaked at $1.91M in Q3 2022. 87 funds tracked by Wall St. Rank hold STRO as of Q3 2025.

  • Cubist Systematic Strategies held 1 share of Sutro Biopharma worth $9 as of Q3 2025.
  • Cubist Systematic Strategies sold 607 Sutro Biopharma shares in Q3 2025, an estimated $5.17K.
  • Sutro Biopharma made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2946 holding.
  • Cubist Systematic Strategies first reported a position in Sutro Biopharma in Q2 2019 and has held it in 18 quarters since.
  • Cubist Systematic Strategies's Sutro Biopharma position peaked at $1.91M in Q3 2022.
  • 87 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.